Danaher Execs Face Investor Suit Over Post-COVID Outlook
Danaher Corp. executives are facing a proposed securities class action in Delaware federal court alleging they profited while misleading stockholders about the slowing sales of its diagnostics and bioprocessing products....To view the full article, register now.
Already a subscriber? Click here to view full article